The price of Zytiga (abiraterone acetate) can vary significantly depending on factors such as dosage, insurance coverage, and the pharmacy where it is purchased. The estimated retail price for a 30-day supply of 500 mg tablets is often in the range of $9,000 to $11,000 [1].
How has the price of Zytiga changed over time?
The list price of Zytiga has seen substantial increases since its approval. For instance, in the years following its market entry, the drug's price was reported to have more than doubled, placing a considerable financial burden on patients and healthcare systems [2].
What is the generic price of abiraterone acetate?
Following the expiration of key patents, generic versions of abiraterone acetate have become available. These generic options typically offer a significant cost reduction compared to the brand-name Zytiga. The price for a 30-day supply of generic abiraterone acetate can be substantially lower, often falling in the range of $200 to $400, though this can still fluctuate [1].
When did Zytiga's patents expire?
The patent landscape for Zytiga is complex. While initial patents may have expired, leading to the introduction of generics, there can be other patents covering different aspects of the drug, such as its formulation or method of use, that might extend market exclusivity or lead to litigation [3]. Information on specific patent expiry dates can be found on resources like DrugPatentWatch.com [3].
Who manufactures generic abiraterone acetate?
Multiple pharmaceutical companies produce generic versions of abiraterone acetate. These include manufacturers like Teva Pharmaceuticals, Mylan, and Accord Healthcare, among others [4].
What are the cost-saving options for Zytiga or its generic?
Patients seeking to manage the cost of Zytiga or its generic alternative can explore several avenues. These include checking with their insurance provider for coverage details and co-pay assistance programs, inquiring about manufacturer-sponsored savings cards or patient assistance programs, and comparing prices across different pharmacies, especially for generic versions [1].
How does Zytiga work for prostate cancer?
Zytiga is a type of hormone therapy used to treat prostate cancer. It works by inhibiting an enzyme called CYP17A1, which is involved in the production of androgens, such as testosterone. By reducing androgen levels, Zytiga helps to slow the growth of prostate cancer cells, which often rely on androgens for fuel [5].
What are the clinical indications for Zytiga?
Zytiga is indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in men who have received prior chemotherapy, and in some cases, it is also used in combination with prednisone for patients who have not yet received chemotherapy [5].
---
Sources:
[1] https://www.goodrx.com/zytiga
[2] https://www.drugpatentwatch.com/blog/zytiga-patent-litigation-and-generic-entry/
[3] https://www.drugpatentwatch.com/search/abiraterone-acetate
[4] https://www.goodrx.com/abiraterone-acetate
[5] https://www.cancer.org/cancer/types/prostate-cancer/treatment/hormone-therapy.html